Pharmaceuticals

SciSparc

SciSparc released FY2025 Annual Earnings on April 29, 2026 (EST), actual revenue USD 856K, actual EPS USD -98.0714

SciSparc released FY2025 Q4 earnings on April 29 (EST), actual revenue USD 856K, actual EPS USD -29.3423

SciSparc Ltd. Announces Acquisition of Medical Endoscope Patents

SciSparc Faces Risk of Deregistration from NASDAQ Due to Insufficient Shareholders' Equity

Neurothera Labs Inc. Plans Acquisition of Quantum Computing Bio-Data Analytics Firm

SciSparc Ltd to Acquire Innovative Medical Endoscopy System Patent Portfolio

SciSparc released FY2025 Q3 earnings on November 20 (EST) with actual revenue of USD 0 and EPS of USD 0

SciSparc released FY2025 9 Months Earnings on November 20 (EST), with actual revenue of USD 0 and EPS of USD -16.5292

SciSparc released FY2025 Semi-Annual earnings on November 18 (EST), actual revenue USD 0, actual EPS USD -16.5292

SciSparc released FY2025 Q2 earnings on November 18 (EST), actual revenue USD -230.5K, actual EPS USD 7.1234

SciSparc released FY2025 Q1 earnings on November 18 (EST), actual revenue USD 230.5K, actual EPS USD -80.6404

SciSparc Ltd. Completes Acquisition of Neurothera Labs Inc.

SciSparc Ltd. Launches Quantum Computing for 3D Protein Modeling

SciSparc Ltd. Signs Agreement to Acquire Majority Stake in Miza III Ventures Inc.

SciSparc's Pharmaceutical Assets and Equity Valued at Approximately $11.6 Million

SciSparc Ltd. Revises Merger Agreement with AutoMax Motors Ltd. and Provides a $4.25 million Transition Loan

SciSparc Ltd. Announces Agreement

SciSparc Ltd. Launches New Plan for Quantum Computing Driven 3D Protein Modeling

SciSparc Receives Approval From AutoMax Shareholders For Merger

SciSparc Ltd. Releases Financial Statement for Merger with AutoMax Motors Ltd.

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

BMGL

OSCR

SPRC

WOOF

MOBX

ADCT

Pre-market trading on Thursday saw significant volatility in biotech stocks driven by acquisitions, clinical updates, and offerings. SciSparc (SPRC) led gainers with a 49% rise to $14.09, followed by Mobix Labs (MOBX) up 26%. Conversely, ADC Therapeutics (ADCT) plummeted 53% to $1.44, while Basel Medical Group (BMGL) fell 24%. Other notable movers included Oscar Health rising 5% and Petco dropping 14%.

nasdaq

Basel Medical

Oscar Health

Petco Health and Wellness

Mobix Labs

ADC Therapeutics SA

Moolec Science SA

Propanc Biopharma

AIM ImmunoTech

Profusa

20/20 Biolabs

Polaryx Therapeutics

LB Pharmaceuticals

Virax Biolabs

Picard Medical

Healthy Choice Wellness

Aditxt

Jin Medical

Syndax Pharma

Jade Biosciences

Nasdaq

MOBIX LABS INC C/WTS (TO PUR COM)

MOOLEC SCIENCE SA C/WTS 30/01/2028(TO PUR COM)

PROPANC BIOPHARMA INC

AIM IMMUNOTECH INC

AIM ImmunoTech Inc.

PROFUSA INC. C/WTS 02/08/2027 (TO PUR COM)

Pre-Market Movers: SPRC, MOBX, ADCT Set The Path

PPCB

BLRX

In Thursday's pre-market session, several healthcare stocks showed significant volatility. Gainers included SciSparc (up 31.7%), BioLine Rx (up 14.93%), and Propanc Biopharma (up 11.31%). Conversely, major losers featured ADC Therapeutics, which plummeted 53.6%, followed by Basel Medical Group (down 26.82%) and Picard Medical (down 16.78%). The report highlights these price movements alongside respective market capitalizations for each company.

benzinga_article

Bioline RX

CytoSorbents

ABVC BioPharma

Cumberland Pharma

Genenta Science S.P.A.

SiNtx Tech

12 Health Care Stocks Moving In Thursday's Pre-Market Session

INOD

SciSparc pre-market up 64.16%; Innodata pre-market down 7.65%; Solidion Tech pre-market up 198.61%; CXApp pre-market up 74.62%; Everbright Digital pre-market up 66.21%

Price Alert

Innodata

Solidion Tech

CXApp

Hot pre-market trades in US stocks: SciSparc up 64.16% pre-market; Innodata down 7.65% pre-market

NBIS

SciSparc pre-market down 10.60%; Nebius pre-market up 6.90%; Genenta Science S.P.A. pre-market up 137.86%; Volato pre-market up 134.29%; Hitek Global Inc. pre-market up 115.07%

Nebius

Volato

Hitek Global Inc.

Pre-market hot trades in US stocks: SciSparc pre-market down 10.60%; Nebius pre-market up 6.90%

SciSparc fell 18.01%; Eli Lilly fell 2.95%, with a transaction volume of $1.375 billion; Johnson & Johnson fell 1.84%, with a transaction volume of $644 million; Merck fell 1.13%, with a transaction volume of $329 million; AstraZeneca rose 0.18%, with a market value of $288 billion

Eli Lilly

Johnson & Johnson

Merck

AstraZeneca

U.S. stock market midday update: SciSparc down 18.01%: profit-taking after acquisition approval, high volatility risk reappears

RKTO

ATYR

SBIO

IBBQ

LABD

Biotech stocks showed significant pre-market activity on Friday. Replimune Group (REPL) led gainers, surging 69% to $7.92, followed by aTyr Pharma (ATYR) up 15%. Other notable gainers included Basel Medical Group and Artiva Biotherapeutics. On the downside, Rocket One Inc. (RKTO) fell 16%, while SciSparc Ltd. (SPRC) dropped 13%. The session highlighted potential breakout opportunities amid shifting sentiment.

Rocket One

ATYR Pharma

Artiva Biotherapeutics

Replimune

Health Care Select Sector SPDR

Proshares UltraShort Nasdaq Biotech

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

iShares US Healthcare Providers

Ark Genomic Revolution ETF

VanEck Biotech ETF

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

SPDR S&P Health

Invesco Biotechnology & Genome ETF

VG Health

Direxion S&P Biotech Bull 3X

Direxion S&P Biotech Bear 3X

Proshares Ultra Nasdaq Biotech

iShares US Pharma

SPDR S&P Biotech

Citius Oncology

Galectin Therap

KALA BIO

Keros Therapeutics

Aethlon Medical

Sunshine Biopharma

BioNexus Gene Lab

Nuwellis

Jupiter Neurosciences

Indaptus Therapeutics

Biorestorative Therapies

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

Pre-Market Movers: REPL, BMGL, SPRC Chart The Course

AKTX

CODX

OTLK

SciSparc (SPRC) gained regulatory approval to acquire a 54% stake in CliniQuantum, boosting its shares by nearly 140%. Co-Diagnostics (CODX) rallied over 50% for the third consecutive day amid Ebola outbreak developments. Akari Therapeutics (AKTX) shares rose 38.46% following positive preclinical data. Outlook Therapeutics (OTLK) jumped 25% as it prepares to resubmit its biologics license application. Polaryx Therapeutics (PLYX) closed a $10 million PIPE financing.

rttnews

Akari Therap

Co-Diagnostics

Outlook Therapeutics

iShares Genomics Immunology and Healthcare ETF

Fortrea

Tevogen Bio

MiNK Therapeutics

TEVOGEN BIO HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM)

Top Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest

ADTX

VSEE

ATPC

On Thursday, Agape ATP (ATPC) shares surged 168.1% to $7.64, while SciSparc (SPRC) rose 135.99% to $10.36. Other gainers included Co-Diagnostics (CODX) up 56.74% and Akari Therapeutics (AKTX) up 44.8%. Conversely, VSee Health (VSEE) fell 21.0% to $0.18, and Aditxt (ADTX) dropped 19.23%. Overall, health care stocks experienced significant volatility.

SciSparc(SPRC.US)